Amgen, Inc. (NASDAQ:AMGN) Awarded Orphan Status For Its SCLC drug

·

·

Amgen, Inc. (NASDAQ:AMGN) Awarded Orphan Status For Its SCLC drug

Jan 6, 2019 | Business. Amgen, Inc. (NASDAQ:AMGN) Awarded Orphan Status For Its SCLC drug. The U.S Food and Drug Administration(FDA)has reportedly granted orphan status to Amgen, Inc. (NASDAQ:AMGN)'s small cell lung cancer (SCLC) treatment.
See Original Article

OPEC Strategy Still a Winner for Members Despite Oil Slump

… by 33 percent last year, to $826 billion, according to Bloomberg calculations, as supply cuts from OPEC and its allies bolstered the average oil price.
See Original Article

Electric Cars Shockingly Long History

Fully-electric motor vehicles didn't begin with Tesla Motors. In fact, in 1900, 1 of every 3 cars on the road was electric (Source: Bloomberg)
See Original Article

Councils to face scrutiny on spending by Dail's public accounts committee

The government is working on new laws to make city and county managers accountable to the Dail's public accounts committee (PAC) for their use of
See Original Article

FDA Accuses Juul and Altria of Backing Off Plan to Stop Youth Vaping

WASHINGTON – The Food and Drug Administration is accusing Juul and Altria of reneging on promises they made to the government to keep e-cigarettes away from minors.
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.